This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tan, T. Y.
Right arrow Articles by He, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tan, T. Y.
Right arrow Articles by He, J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2008, p. 2393-2395, Vol. 46, No. 7
0095-1137/08/$08.00+0     doi:10.1128/JCM.00740-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Microbiological Characteristics, Presumptive Identification, and Antibiotic Susceptibilities of Staphylococcus lugdunensis{triangledown}

Thean Yen Tan,1* Siew Yong Ng,1 and Jie He2

Division of Laboratory Medicine, Changi General Hospital, Singapore,1 Department of Pathology, Singapore General Hospital, Singapore2

Received 17 April 2008/ Accepted 5 May 2008


arrow
ABSTRACT
 
This study validated abbreviated methods for the presumptive identification of Staphylococcus lugdunensis and studied the antibiotic susceptibilities of 106 isolates. The combination of positive responses to ornithine and pyrrolidonyl arylamidase identified all S. lugdunensis isolates. Resistance to penicillin and methicillin was detected in 27 and 5% of isolates, respectively.


arrow
TEXT
 
Staphylococcus lugdunensis, a coagulase-negative staphylococcus, has clinical characteristics that resemble those of the coagulase-positive Staphylococcus aureus. Infections attributed to S. lugdunensis include infective endocarditis (19), bacteremia, meningitis (6), bone and joint infections (7), and soft-tissue infections (16). S. lugdunensis generally is susceptible to anti-staphylococcal antibiotics (18), but increasing penicillin resistance has been reported (9, 13). Meanwhile, oxacillin susceptibility breakpoints for S. lugdunensis were changed in 2005 (3), and oxacillin disc breakpoints were revised in 2005 and subsequently replaced by cefoxitin disc breakpoints in 2006 (2). The current reference method for the identification of coagulase-negative staphylococci (1) is labor-intensive. Screening for S. lugdunensis by detecting clumping factor (15, 21) or using a limited number of biochemical tests (5, 12, 15) has been proposed, but these methods have been evaluated only against small numbers of S. lugdunensis isolates.

The aims of this study were to evaluate the use of simple screening strategies for the identification of S. lugdunensis, to comprehensively describe the microbiological characteristics of S. lugdunensis, and to evaluate the antibiotic susceptibility of clinical isolates.

The accuracy of three abbreviated identification protocols and two commercial identification kits (ID 32 Staph and Vitek ID-GP; both from bioMérieux, France) was evaluated against a collection of coagulase-negative staphylococci that were isolated from clinical samples. Isolates from the collection were identified using a panel of 30 phenotypic and biochemical tests (1) and included Staphylococcus capitis (n = 7), Staphylococcus caprae (n = 5), Staphylococcus cohnii (n = 2), Staphylococcus epidermidis (n = 14), Staphylococcus haemolyticus (n = 24), Staphylococcus hominis (n = 3), Staphylococcus lugdunensis (n = 46), Staphylococcus saprophyticus (n = 2), and Staphylococcus warneri (n = 3). The identification of 10 isolates (belonging to S. haemolyticus, S. cohnii, S. epidermidis, and S. lugdunensis) was further confirmed by sequencing a 457-bp sequence of the 16S rRNA gene (8). For the three abbreviated identification protocols, isolates were tested for the presence of pyrrolidonyl arylamidase (PYR) (Oxoid, United Kingdom), ornithine decarboxylase (BioMedia, Malaysia), and urease (BioMedia, Malaysia); trehalose utilization; alkaline phosphatase activity; and mannose utilization (the last three substances were from Rosco, Denmark). In the first identification protocol, isolates that were positive for both PYR and ornithine decarboxylase were identified as S. lugdunensis. In the second identification protocol, isolates that were positive for PYR, ornithine decarboxylase, and mannose utilization were identified as S. lugdunensis. The third identification protocol identified an isolate as S. lugdunensis if it was positive for trehalose and ornithine decarboxylase and negative for alkaline phosphatase (12). The first and second identification protocols correctly identified all 46 isolates of S. lugdunensis (sensitivity, 100%), while the third testing protocol identified 42 isolates of S. lugdunensis (sensitivity, 91%). None of the other staphylococcal species was misidentified as S. lugdunensis by the three protocols (specificity, 100%). ID 32 Staph correctly identified 45 (98%) isolates of S. lugdunensis, and Vitek ID-GP correctly identified 43 (93%) isolates of S. lugdunensis.

The 46 strains of S. lugdunensis were subcultured onto trypticase-soy agar plates with 5% sheep blood and incubated in ambient atmosphere at 35°C for 3 days. Colonial morphology was observed after 24, 48, and 72 h of incubation. Colonies were 1 mm in diameter after 24 h of incubation and increased to 3 mm after 48 h at 35°C. Forty (87%) isolates showed a narrow border of beta-hemolysis after 24 h of incubation. After 48 h of incubation, 39 (85%) isolates showed significant beta-hemolytic activity, and 4 isolates (9%) showed slight beta-hemolysis. Colonies at 24 h typically were opaque white, with a glossy sheen (n = 40; 87%). At 48 and 72 h, 13 isolates (28%) developed a yellow-white hue resembling that of S. aureus. S. lugdunensis isolates had a characteristic sweet, hay-like odor resembling that of the screwpine leaf, and this was prominent in 38 (79%) isolates after 48 h of incubation.

The detection of clumping factor/protein A using three commercial latex agglutination kits, Pastorex Staph (Bio-Rad, France), Staphaurex, and BactiStaph (both from Remel, United States), was performed on overnight cultures. Rapid and clear agglutination was classified as a positive result, while slower and less distinct agglutination was classified as a weak positive result. The interpretation of a positive agglutination test was always made with reference to the manufacturer's instructions. All isolates were tested for the presence of free coagulase using a rabbit plasma tube coagulase test method. The three latex agglutination kits showed different performance characteristics. BactiStaph and Pastorex Staph showed strongly positive agglutination for 49 and 42% of S. lugdunensis isolates, respectively, while strongly positive agglutination was present in only 9% of isolates that were tested by Staphaurex. For both positive and weak-positive agglutination reactions, the test kit positivity was 73, 76, and 17% for BactiStaph, Pastorex Staph, and Staphaurex, respectively. All isolates were negative for free coagulase.

Antibiotic susceptibility testing was performed on a separate collection of 106 isolates of S. lugdunensis that were collected prospectively from clinical specimens from 2004 to 2006 and identified using the first identification protocol. Antibiotic susceptibilities were performed by disk diffusion and were interpreted using CLSI guidelines (4), except for oxacillin, for which the last applicable guidelines from 2005 were applied (3). MICs of penicillin and oxacillin were determined by agar dilution. All isolates were screened for the mecA gene (20), and mecA-positive isolates were tested for the presence of pbp2' by latex agglutination (Oxoid, United Kingdom) using previously described methods (10). The species identification of all mecA-positive S. lugdunensis isolates was confirmed by 16S rRNA gene sequencing. The antibiotic susceptibilities of 106 clinical isolates are listed in Table 1. Twenty-nine isolates (27%) were resistant to penicillin by agar dilution. The modal oxacillin MIC was 1 µg/ml (Table 2), which is higher than those for most other staphylococcal species but similar to that for S. saprophyticus and S. cohnii (11, 13). The oxacillin MICs for five isolates were ≥4 µg/ml, and all were positive for both mecA and pbp2'. Current cefoxitin disk breakpoints accurately detected mecA-positive isolates, as opposed to oxacillin disk breakpoints (susceptibility breakpoint, ≤13 mm; resistance breakpoint, ≥10 mm), which had poor sensitivity (80%) and specificity (65%).


View this table:
[in this window]
[in a new window]

 
TABLE 1. Antibiotic susceptibilities of S. lugdunensis strains based on disc susceptibility testinga


View this table:
[in this window]
[in a new window]

 
TABLE 2. No. of strains positive or negative for the mecA gene according to oxacillin MICsa

This study comprehensively examined the use of abbreviated protocols for the presumptive identification of S. lugdunensis. Our results show that the use of clumping factor may not be a reliable screening method to identify this organism, as results appear to be kit dependent. The two-test protocol that utilized ornithine decarboxylase and PYR accurately identified all of our S. lugdunensis strains. The suggested addition of mannose utilization to differentiate S. haemolyticus from S. lugdunensis (15) was not required to improve the specificity of this protocol. Of the commercial kits, the ID 32 Staph kit performed marginally better than the Vitek ID-GP card.

S. lugdunensis generally has been characterized as being susceptible in vitro to most antibiotics. Early studies reported penicillin resistance rates of <4% (14), while more recent studies report penicillin resistance rates of 12 to 15% (9, 13). Only one methicillin-resistant isolate has been reported (17). Over a quarter of clinical isolates of S. lugdunensis in our population were resistant to penicillin, while methicillin resistance was present in 5% of study isolates. However, other than that for tetracycline, resistance to non-beta-lactam antibiotics was low. Current CLSI breakpoints for oxacillin MIC and cefoxitin disc testing clearly differentiate mecA-positive strains of S. lugdunensis. The latex detection of pbp2 also is a viable alternative.

This study validates a simple screening strategy to differentiate S. lugdunensis from other coagulase-negative staphylococci. This will improve the recognition of clinical disease and the surveillance of antibiotic resistance in S. lugdunensis.


arrow
ACKNOWLEDGMENTS
 
This study was funded by a grant from the National Medical Research Council.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Division of Laboratory Medicine, Changi General Hospital, 2 Simei Street 3, Singapore, 529889. Phone: 65-68504934. Fax: 65-64269507. E-mail: thean_yen_tan{at}cgh.com.sg Back

{triangledown} Published ahead of print on 14 May 2008. Back


arrow
REFERENCES
 
    1
  1. Bannerman, T. L. 2003. Staphylococcus, Micrococcus, and other catalase-positive cocci that grow aerobically, p. 384-404. In P. R. Murray, E. J. Baron, J. H. Jorgenson, M. A. Pfaller, and R. H. Yolken (eds.), Manual of clinical microbiology, 8th ed., vol. 1. American Society for Microbiology, Washington, DC.
  2. 2
  3. Clinical Laboratory Standards Institute. 2006. Performance standards for antimicrobial disk susceptibility tests; approved standard. M2-A9. Clinical Laboratory Standards Institute, Wayne, PA.
  4. 3
  5. Clinical Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; 15th informational supplement. NCCLS/CLSI M100-S15. Clinical Laboratory Standards Institute, Wayne, PA.
  6. 4
  7. Clinical Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. M100-S17. Clinical Laboratory Standards Institute, Wayne, PA.
  8. 5
  9. De Paulis, A. N., S. C. Predari, C. D. Chazarreta, and J. E. Santoianni. 2003. Five-test simple scheme for species-level identification of clinically significant coagulase-negative staphylococci. J. Clin. Microbiol. 41:1219-1224.[Abstract/Free Full Text]
  10. 6
  11. Ebright, J. R., N. Penugonda, and W. Brown. 2004. Clinical experience with Staphylococcus lugdunensis bacteremia: a retrospective analysis. Diagn. Microbiol. Infect. Dis. 48:17-21.[CrossRef][Medline]
  12. 7
  13. Greig, J. M., and M. J. Wood. 2003. Staphylococcus lugdunensis vertebral osteomyelitis. Clin. Microbiol. Infect. 9:1139-1141.[CrossRef][Medline]
  14. 8
  15. Harmsen, D., C. Singer, J. Rothganger, T. Tonjum, G. S. de Hoog, H. Shah, J. Albert, and M. Frosch. 2001. Diagnostics of Neisseriaceae and Moraxellaceae by ribosomal DNA sequencing: ribosomal differentiation of medical microorganisms. J. Clin. Microbiol. 39:936-942.[Abstract/Free Full Text]
  16. 9
  17. Hellbacher, C., E. Tornqvist, and B. Soderquist. 2006. Staphylococcus lugdunensis: clinical spectrum, antibiotic susceptibility, and phenotypic and genotypic patterns of 39 isolates. Clin. Microbiol. Infect. 12:43-49.[CrossRef][Medline]
  18. 10
  19. Hussain, Z., L. Stoakes, S. Garrow, S. Longo, V. Fitzgerald, and R. Lannigan. 2000. Rapid detection of mecA-positive and mecA-negative coagulase-negative staphylococci by an anti-penicillin binding protein 2a slide latex agglutination test. J. Clin. Microbiol. 38:2051-2054.[Abstract/Free Full Text]
  20. 11
  21. Hussain, Z., L. Stoakes, V. Massey, D. Diagre, V. Fitzgerald, S. El Sayed, and R. Lannigan. 2000. Correlation of oxacillin MIC with mecA gene carriage in coagulase-negative staphylococci. J. Clin. Microbiol. 38:752-754.[Abstract/Free Full Text]
  22. 12
  23. Ieven, M., J. Verhoeven, S. R. Pattyn, and H. Goossens. 1995. Rapid and economical method for species identification of clinically significant coagulase-negative staphylococci. J. Clin. Microbiol. 33:1060-1063.[Abstract]
  24. 13
  25. Mateo, M., J. R. Maestre, L. Aguilar, F. Cafini, P. Puente, P. Sanchez, L. Alou, M. J. Gimenez, and J. Prieto. 2005. Genotypic versus phenotypic characterization, with respect to susceptibility and identification, of 17 clinical isolates of Staphylococcus lugdunensis. J. Antimicrob. Chemother. 56:287-291.[Abstract/Free Full Text]
  26. 14
  27. Paterson, D. L., and N. Nuttall. 1997. Serious infections due to Staphylococcus lugdunensis. Aust. N. Z. J. Med. 27:591.[Medline]
  28. 15
  29. Schnitzler, N., R. Meilicke, G. Conrads, D. Frank, and G. Haase. 1998. Staphylococcus lugdunensis: report of a case of peritonitis and an easy-to-perform screening strategy. J. Clin. Microbiol. 36:812-813.[Abstract/Free Full Text]
  30. 16
  31. Tan, T. Y., S. Y. Ng, and W. X. Ng. 2006. Clinical significance of coagulase-negative staphylococci recovered from nonsterile sites. J. Clin. Microbiol. 44:3413-3414.[Abstract/Free Full Text]
  32. 17
  33. Tee, W. S., S. Y. Soh, R. Lin, and L. H. Loo. 2003. Staphylococcus lugdunensis carrying the mecA gene causes catheter-associated bloodstream infection in premature neonate. J. Clin. Microbiol. 41:519-520.[Abstract/Free Full Text]
  34. 18
  35. van der Mee-Marquet, N., A. Achard, L. Mereghetti, A. Danton, M. Minier, and R. Quentin. 2003. Staphylococcus lugdunensis infections: high frequency of inguinal area carriage. J. Clin. Microbiol. 41:1404-1409.[Abstract/Free Full Text]
  36. 19
  37. Van Hoovels, L., P. De Munter, J. Colaert, I. Surmont, E. Van Wijngaerden, W. E. Peetermans, and J. Verhaegen. 2005. Three cases of destructive native valve endocarditis caused by Staphylococcus lugdunensis. Eur. J. Clin. Microbiol. Infect. Dis. 24:149-152.[CrossRef][Medline]
  38. 20
  39. Vannuffel, P., J. Gigi, H. Ezzedine, B. Vandercam, M. Delmee, G. Wauters, and J. L. Gala. 1995. Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR. J. Clin. Microbiol. 33:2864-2867.[Abstract]
  40. 21
  41. Zbinden, R., F. Muller, F. Brun, and A. von Graevenitz. 1997. Detection of clumping factor-positive Staphylococcus lugdunensis by Staphaurex Plus. J. Microbiol. Methods 31:95-98.[CrossRef]


Journal of Clinical Microbiology, July 2008, p. 2393-2395, Vol. 46, No. 7
0095-1137/08/$08.00+0     doi:10.1128/JCM.00740-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tan, T. Y.
Right arrow Articles by He, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tan, T. Y.
Right arrow Articles by He, J.